Keyphrases
Intervertebral Disc
100%
Celecoxib
100%
Canine Model
100%
Intradiscal
100%
Intervertebral Disc Degeneration
57%
Cyclooxygenase-2 Inhibitors
42%
Prostaglandin E2
28%
Nucleus Pulposus
28%
Controlled Release
28%
Local Delivery
28%
Polyesteramide
28%
Inflammation
14%
Adverse Effects
14%
Beneficial Effects
14%
Quantitative PCR
14%
Magnetic Resonance Imaging
14%
Canine
14%
Computed Tomography
14%
Clinical Efficacy
14%
Low Back Pain
14%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
14%
Tissue Level
14%
Sustained Release
14%
MRI Measurements
14%
Indirect Evidence
14%
Macroscopic Examination
14%
Proteoglycan Content
14%
Chronic Back Pain
14%
Sustained Delivery
14%
Immunopositivity
14%
Intervertebral Disc Degeneration Model
14%
MRI-histology
14%
Anti-catabolic Effects
14%
Image Evaluation
14%
Alternative Treatment Strategies
14%
Neuronal Growth Factor
14%
Inflammation Inhibition
14%
Medicine and Dentistry
Intervertebral Disk
100%
Celecoxib
100%
Microsphere
100%
Intervertebral Disk Degeneration
57%
In Vitro
42%
Cyclooxygenase 2 Inhibitor
42%
Magnetic Resonance Imaging
28%
Nucleus Pulposus
28%
Controlled Release
28%
Prostaglandin E2
28%
Side Effect
14%
Low Back Pain
14%
Computer Assisted Tomography
14%
Sustained Drug Release
14%
Clinical Study
14%
Real-Time Polymerase Chain Reaction
14%
Nonsteroid Antiinflammatory Agent
14%
Growth Factor
14%
Proteoglycan
14%
Adverse Effect
14%
Neuroscience
Microsphere
100%
Intervertebral Disk
100%
Celecoxib
100%
In Vivo
42%
In Vitro
42%
COX-2 Inhibitor
42%
Prostaglandin E2
28%
Nucleus Pulposus
28%
Magnetic Resonance Imaging
14%
Adverse Effect
14%
Magnetic Resonance Imaging
14%
Proteoglycan
14%
Computed Tomography
14%
Real-Time Polymerase Chain Reaction
14%
Non-Steroidal Anti-Inflammatory Drug
14%
Growth Factor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Celecoxib
100%
Canine Model
100%
Microsphere
100%
Intervertebral Disk Degeneration
57%
COX-2 Inhibitor
42%
Controlled Release
28%
Inflammation
28%
Prostaglandin E2
28%
Clinical Study
14%
Non-Steroidal Anti-Inflammatory Drug
14%
Growth Factor
14%
Sustained Release
14%
Side Effect
14%
Low Back Pain
14%
Proteoglycan
14%
Immunology and Microbiology
Intervertebral Disk
100%
Microsphere
100%
Canine Model
100%
Cyclooxygenase
42%
Magnetic Resonance Imaging
28%
Nucleus Pulposus
28%
Prostaglandin E2
28%
Real-Time Polymerase Chain Reaction
14%
Growth Factor
14%
Back
14%
Computer Assisted Tomography
14%
Tissue Level
14%
Sustained Drug Release
14%
Proteoglycan
14%